Cargando…
Development and validation of novel automatable assay for cholesterol efflux capacity
During the past decade, evaluation of high-density lipoprotein (HDL) functionality has been well studied for predicting cardiovascular disease (CVD) risk. Cholesterol efflux capacity (CEC) is the strongest candidate as the biomarker out of various HDL antiatherosclerotic functions. However, CEC has...
Autores principales: | Mutsuda, Yume, Miyakoshi, Tsunehiro, Horiuchi, Yuna, Kameda, Takahiro, Tozuka, Minoru, Ohkawa, Ryunosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905788/ https://www.ncbi.nlm.nih.gov/pubmed/36645426 http://dx.doi.org/10.1042/BSR20221519 |
Ejemplares similares
-
Comparison of a novel cholesterol efflux assay using immobilized liposome-bound gel beads with the conventional method
por: Horiuchi, Yuna, et al.
Publicado: (2020) -
Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads
por: Horiuchi, Yuna, et al.
Publicado: (2019) -
Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells
por: Horiuchi, Yuna, et al.
Publicado: (2018) -
Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells
por: Yano, Kouji, et al.
Publicado: (2016) -
Development of internal standard for lipoprotein subclass analysis using dual detection gel-permeation high-performance liquid chromatography system
por: Ogino, Mei, et al.
Publicado: (2022)